Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 13, 2014

Cancer biologist Robert Benezra explains angiogenesis, the process by which new blood vessels form, and how it relates to cancer research.

Pictured: Talia Zaider
Support
By Jenifer Goodwin, BA, Freelance Writer  |  Wednesday, March 12, 2014

Clinical psychologist Talia Zaider offers guidance to those whose friend or loved one is facing terminal illness.

Pictured: Jan Grimm
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Monday, March 10, 2014

Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.

Event
By Julie Grisham, MS, Science Writer/Editor  |  Friday, March 7, 2014

Cycle for Survival, Memorial Sloan Kettering’s indoor team cycling fund-raiser, raises money exclusively for research on rare cancers.

Pictured: Susan Prockop & Lucas T.
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, March 6, 2014

Memorial Sloan Kettering physician-scientists have prevented a dangerous complication of stem cell transplantation using immune cells donated from a third party.

Vincent Laudone
Perspective
By Vincent Laudone, MD, Co-Director for Robotic Surgery  |  Tuesday, March 4, 2014

Our conversation about active surveillance of prostate cancer continues. Let’s take a closer look at our protocols for selecting and monitoring patients.

Pictured: Marcel van den Brink & Robert Jenq
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, March 3, 2014

Research suggests that the presence of a type of bacteria called Blautia, which occurs naturally in the body, may prevent graft-versus-host disease, a potentially fatal side effect of bone marrow and stem cell transplants.

 Pictured: Cancer cell on blood vessel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, February 27, 2014

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.

Pictured: Sergio Giralt
Honor
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 26, 2014

Memorial Sloan Kettering’s leadership in blood and marrow stem cell transplantation is on full display at the 2014 BMT Tandem Meeting.

Pictured: William Jarnagin
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, February 25, 2014

Thanks to recent treatment advances, many people diagnosed with liver cancer today can expect to survive the disease. But experience counts.

Pictured: Abraham Wu
Ask the Expert
By Jim Stallard, MA, Writer/Editor  |  Monday, February 24, 2014

CyberKnife is a brand name for one of several available devices that deliver intense doses of radiation with very high accuracy.

Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, February 20, 2014

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Pictured: Diane Reidy
Feature
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, February 19, 2014

Cycle for Survival, Memorial Sloan Kettering’s nationwide indoor team cycling event, helps support research into rare cancers. Three researchers discuss how these funds benefit their research.

Pictured: Vivian Tabar
Profile
By Celia Gittelson, BA  |  Monday, February 17, 2014

Viviane Tabar performs complex surgeries for patients with brain tumors and, outside the operating room, focuses on the relationship between stem cells and brain cancers.

Q&A
By Media Staff  |  Friday, February 14, 2014

Breast cancer surgeon Monica Morrow discusses how surgery for breast cancer is evolving in the modern era of more-effective drug therapy.

Center News

Stay Informed

Get the latest information about cancer care and research every month.